Skip to content

Bioavailability Comparison of Valsartan 320 mg Tablets (Test vs. Reference Product)

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-527569-31-00
Enrollment
34
Registered
2026-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable (submitted trial is a BE study in healthy participants)

Interventions

None listed

Sponsors

ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 26, 2026